---

Johnson & Johnson New Brunswick Since the mid-1880’s, when the newly created Johnson & Johnson began making the first antiseptic surgical dressings, the company has grown to become the world’s largest and most comprehensive manufacturer of health care products serving the consumer, pharmaceutical and professional markets. Johnson & Johnson holds 3,232 active U.S. patents and 16,622 active international patents along with 46,128 trademark registrations and 4,316 unique trademarks. The company’s achievements are rooted in a century-long commitment to developing novel technologies into new, cost-effective products that enhance or save lives, a highly entrepreneurial culture, a decentralized structure and a strong ethical core. More than 36 percent of 1995 sales were from products introduced in the past five years. In 1996, Johnson & Johnson’s Research and Development investment reached $1.9 billion and included more than 7,200 researchers, making the company the only health care firm among the top 10 U.S. corporations in terms of R&D spending. When most surgeons were still ignoring Lister’s germ theory, Johnson & Johnson launched antiseptic wound dressings, and then, with new technology, the world’s first sterile bandages. Today, Johnson & Johnson is the world market leader in oral contraceptives, surgical stents, disposable contact lenses, antifungal drugs, blood glucose monitoring systems, sutures, medical diagnostics, over-the-counter drugs and instruments for minimally-invasive surgery. The company is also the U.S. leader in clinical chemistry analyzers, neurosurgical instruments and non-invasive blood pressure monitors. Johnson & Johnson was the recipient of the 1996 National Medal of Technology, the nation’s highest honor for technological innovation.